Overstatements in abstract conclusions claiming effectiveness of interventions in psychiatry: A study protocol for a meta-epidemiological investigation by Suganuma, Aya M. et al.
Title
Overstatements in abstract conclusions claiming effectiveness
of interventions in psychiatry: A study protocol for a meta-
epidemiological investigation
Author(s)Suganuma, Aya M.; Shinohara, Kiyomi; Imai, Hissei;Takeshima, Nozomi; Hayasaka, Yu; Furukawa, Toshi A.




This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-
NC 4.0) license, which permits others to distribute, remix,
adapt, build upon this work non-commercially, and license
their derivative works on different terms, provided the original




Overstatements in abstract conclusions
claiming effectiveness of interventions
in psychiatry: a study protocol for a
meta-epidemiological investigation
Aya M Suganuma, Kiyomi Shinohara, Hissei Imai, Nozomi Takeshima,
Yu Hayasaka, Toshi A Furukawa
To cite: Suganuma AM,




in psychiatry: a study





▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2015-009832).
Received 26 August 2015




Graduate School of Medicine/







Introduction: Abstracts are the major and often the
most important source of information for readers of
the medical literature. However, there is mounting
criticism that abstracts often exaggerate the positive
findings and emphasise the beneficial effects of
intervention beyond the actual findings mentioned in
the corresponding full texts. In order to examine the
magnitude of this problem, we will introduce a
systematic approach to detect overstated abstracts and
to quantify the extent of their prevalence in published
randomised controlled trials (RCTs) in the field of
psychiatry.
Methods and analysis: We will source RCTs
published in 2014 from the Cochrane Register of
Controlled Trials (CENTRAL) that claim effectiveness of
any intervention for mental disorders. The abstract
conclusions will be categorised into three types:
superior (only stating significant superiority of
intervention to control), limited (suggesting that
intervention has limited superiority to control) and
equal (claiming equal effectiveness of intervention as
control). The full texts will also be classified as one of
the following based on the primary outcome results:
significant (all primary outcomes were statistically
significant in favour of the intervention), mixed
(primary outcomes included both significant and non-
significant results) or all non-significant results. By
comparing the abstract conclusion classification and
that of the corresponding full text, we will assess
whether each study exhibited overstatements in its
abstract conclusion.
Ethics and dissemination: This trial requires no
ethical approval. We will publish our findings in a peer-
reviewed journal.
Trial registration number: UMIN000018668; Pre-
results.
INTRODUCTION
Abstracts of research articles are of signiﬁ-
cant importance for readers. They are often
the primary source of information on the
medical research. Partly owing to lack of
time, clinicians often only read the abstracts.1
Moreover, owing to the limited availability of
free full texts,2 abstracts are often the single
source of information on the research for
many readers. As a result, as stated in
Consolidated Standards of Reporting Trials
(CONSORT), ‘readers often base their ﬁrst
assessment of a trial solely on the informa-
tion in the abstract’,3 and thus abstracts
potentially impact the interpretation of the
results substantially.
As part of the recent effort to enhance the
quality of reporting,4 reformulation of the
abstract structure5 and the reporting guide-
line for abstracts have been proposed.3
However, leading studies have reported that
abstracts of research articles frequently
contain bias. Boutron et al6 studied ‘spin’ in
the abstracts of 72 randomised controlled
trials (RCTs) with non-signiﬁcant primary
outcomes. Their deﬁnition of spin included:
(1) a focus on statistically signiﬁcant results,
(2) interpreting non-signiﬁcant results as
Strengths and limitations of this study
▪ Detects overstatements systematically without
using subjective definition(s) and minimises
investigators’ arbitrary judgements.
▪ Provide practical suggestions for general readers
on how to discern and detect overstated abstract
conclusions when they first read abstracts.
▪ Our evaluation process follows the steps how
articles are read generally, and thus our
approach is easy to understand for general
readers.
▪ Papers published in some journals are systemat-
ically excluded, for their reporting style does not
have conclusions as a subheading under the
abstract section.
▪ Owing to the nature of our framework, we will
not be able to analyse other potential biases,
such as selective reporting and publication bias.
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showing treatment equivalence or comparable effective-
ness, and (3) claiming or emphasising the beneﬁcial
effect of treatment despite non-signiﬁcant results. They
reported that 42 (58.3%) of the abstract conclusions
exhibited some form of spin. Mathieu et al7 analysed 105
trial reports in rheumatology about ‘misleading’
abstracts. They classiﬁed a trial as having misleading
abstract if the study authors discussed only secondary
outcomes or subgroup analyses in abstract, and stated
conclusions contradictory to the actual study results.
According to them, 24 (23%) of the studied reports had
such misleading abstracts. For non-randomised trials,
Lazarus et al8 reported that 84% (107/128) of the
studies contained at least one type of spin in their
abstracts, with a high level of spin detected among 48%
of the articles. Roest et al9 reported that in the ﬁeld of
psychiatry, three trials had a spin out of 16 non-positive
trials with second-generation antidepressants for anxiety
disorders, and Amos10 reviewed 38 published reports on
early interventions for psychosis and found spin in 66%
of them.
While the above studies shed some light on the
important characteristics of distorted abstract reporting,
they have their own limitations. First of all, their strict
judgement may leave some room for discussion. For
example, Boutron et al considered a trial as having ‘spin’
even though the ﬁrst sentence of its abstract conclusion
stated ‘this trial did not demonstrate signiﬁcant improve-
ment in the primary or secondary end points in the
active treatment group vs the group receiving placebo’.11
Second, their analyses covered a selected portion of the
publication. Boutron et al excluded the majority of pub-
lished trials due to their having statistically signiﬁcant
results. Also, both left out trials with ambiguous primary
outcome(s) or of non-inferiority design. Lazarus et al
only included non-randomised trials, and Roest et al and
Amos only assessed trials on speciﬁc mental disorders.
Lastly, they focused primarily on the investigators’ per-
spectives and provided little practical suggestions for
general readers on how to discern and detect overstated
abstract conclusions when they ﬁrst read abstracts.
We propose a systematic approach that minimises
investigators’ judgemental arbitrariness and potential
bias in identifying and analysing overstated abstracts,
and present results in a simple, reader-friendly table
format. On the basis of our ﬁndings, we aim to provide
insights into how to appraise the reported ﬁndings in
abstract conclusions from the readers’ viewpoint.
Objectives
We aim to evaluate the prevalence and patterns of over-
stated abstract conclusions in trials claiming effectiveness
of interventions in psychiatry by comparing the abstract
conclusion and the results of the corresponding full
text. In addition, we will examine their predictors. The
primary outcome of this research is the quantiﬁed preva-
lence of the overstated abstract conclusions, and our sec-
ondary outcome is the difference in the extent of
prevalence between those abstract conclusions that only
mention good results of the intervention arm and those
that include limited results.
METHODS AND ANALYSIS
Study selection
We will use the Cochrane Central Register of Controlled
Trials (CENTRAL) to identify all RCTs claiming effect-
iveness of interventions for mental disorders published
in the English language in 2014. We will use the Medical
Subject Headings (MeSH) term ‘mental disorders’,
MeSH-term subheadings ‘drug therapy’ and ‘therapy’,
and publication type ‘randomised controlled trial’ (see
table 1).
The selection will cover any kinds of interventions,
from common pharmacological intervention to
non-drug therapy such as aromatherapy and exercise.
We will include reports whose abstract conclusions claim
superior or equal effectiveness of intervention to
control. We will focus on the primary outcome (if
stated) or all outcomes (if none is declared primary) in
the abstract conclusions. We will exclude reports in
which the primary outcomes were declared and it was
explicitly stated that they were not signiﬁcant, because
such description would be accurate and leave no room
for overstatement. For instance, an abstract stating ‘while
the primary outcome was not signiﬁcant, secondary mea-
sures showed relevant beneﬁts of intervention over
control’ will be excluded. We will exclude studies
without a conclusion or discussion section in the
abstract, trials with more than two arms, and unpub-
lished trials. Secondary analysis studies, feasibility studies
and cost-effectiveness studies will not be included either.
Since this is a qualitative, descriptive research, it is not
within our scope to assess its statistical signiﬁcance.
Therefore, while sample size calculation is not essential,
we shall target an outcome with a margin of error of
10%± and a CI of 95%. Assuming that the proportion of
overstated studies is 50%, the desired sample size is cal-
culated to be around 100.
Date extraction
The selected studies will be divided into two sets and
two pairs of assessors will analyse each set. To check for
Table 1 Searching strategy, Cochrane Central Register of
Controlled Trials
Search terms
#1 MeSH descriptor: [Mental Disorders] explode all trees
and with qualifier(s): [Therapy—TH]
#2 MeSH descriptor: [Mental Disorders] explode all trees
and with qualifier(s): [Drug therapy—DT]
#3 ‘randomised controlled trial’:pt Publication Year from
2014 to 2014 (Word variations have been searched)
#4 (#1 or #2) and #3
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eligibility, each pair of assessors will screen the title and
abstract of each candidate study independently in a
given set, respectively. Afterwards, each pair will read
the full text to decide whether the study meets the
inclusion criteria. Then the pairs will swap the screened
set. By doing so, we can ascertain that the assessors
have no previous knowledge of the given trial when
they categorise the abstract and the full text. The agree-
ment within the pair will be reported at each step of
assessments. This is to ensure that our analysis resem-
bles the way that general readers read and evaluate a
study, as well as to maintain the independence of
appraisal from any inﬂuence of the full text on the
abstract and vice versa.
Following the screening and check, we will collect
information from each study in the following three
steps: categorisation of abstracts, classiﬁcation of primary
outcomes, and assessing inconsistency between the two.
In each step, we will extract the relevant data from each
study using the Excel spreadsheet specially made for this
trial. The data include: the type of intervention, targeted
mental illness, the region where the study was con-
ducted, the number of randomised patients, study
design, primary outcomes supposed in the abstract con-
clusion, the results of primary and secondary outcomes
in the full text. Data extraction, categorisation of
abstracts and the evaluation of the primary outcomes
will be done independently by the two teams consisting
of two or three assessors. Any disagreements in the team
may be resolved by discussions with a third party. The
citation will be recorded in each study PDF document
and kept as a reference.
Categorisation of abstracts
First, we will categorise each abstract conclusion into
one of the three types according to the level of effective-
ness it claims without reading their full text. If a trial
only stated signiﬁcant effectiveness of the intervention
in its abstract conclusion, it will be classiﬁed as ‘super-
ior’. On the other hand, a trial reporting signiﬁcant and
non-signiﬁcant ﬁndings with respect to the interven-
tion’s efﬁcacy will be considered as ‘limited’ (eg, ‘treat-
ment signiﬁcantly improved quality of life than the
control, but not depression’, or ‘treatment improved
quality of life and anxiety, and had limited effect on
depression’). Trials claiming equal effectiveness of inter-
vention to control (eg, ‘intervention was equally effective
as control’) will be categorised as ‘equal’. Note that our
judgement will be based solely on the abstract conclu-
sion, regardless of the primary outcome results discussed
in the results section of the abstract or full text.
Classification of results of primary outcome in full text
Second, we will assess the level of statistical evidence for
their ﬁndings in primary outcome(s) in full text, and
identify them into one of the three: signiﬁcant (all
primary outcomes were statistically signiﬁcant), mixed
(primary outcome included statistically signiﬁcant and
non-signiﬁcant results), and all non-signiﬁcant. Note
that no results of any secondary analysis or subgroup
analysis results will be taken into consideration when
determining the category.
We will deﬁne those trials as having an ‘ambiguous
primary outcome’ if they did not explicitly state any
outcome(s) as ‘primary’ or ‘main analysis’, except when
they only measured a single outcome. In such cases, the
single outcome will be considered the primary outcome.
When a trial did not specify the primary time point, the
following time points will be regarded as primary: end
of treatment in trials studying the effectiveness of the
acute treatment, the last follow-up in trials studying
maintenance of the effectiveness, and the end of treat-
ment and last follow-up in trials studying both, or in
case the objective was unclear. We will also check if a
trial was designed as a superiority trial or non-inferiority
trial.
Furthermore, we will call a trial lacking vital informa-
tion a ‘sub-quality trial’. For example, a trial without stat-
istical analysis of the main comparison, or having no
assessment at the end of treatment will be classiﬁed as
‘sub-quality trial’.
Assessing inconsistency between abstract and results
in full text
By comparing the classiﬁcation of the abstract conclu-
sion and that of the full text for each study, we can
determine whether its abstract conclusion was overstated
and ﬁnd the patterns of overstatements as shown in
table 2. Naturally, a trial with an abstract conclusion cate-
gorised as ‘superior’ should have statistically signiﬁcant
results in all of their declared primary outcomes.
Table 2 Overstatement(s) in abstract conclusion
Primary outcome
(supposed) in
abstract conclusion Primary outcome in full text
Not overstated
1. Superior Significant: All significant primary
outcomes
2. Limited Mixed: significant and non-
significant primary outcomes
3. Equal Non-significant in non-inferiority
design
Overstated
4. Superior 4.1 Mixed or Non-significant:
Including non-significant primary
outcomes
4.2 Ambiguous primary outcomes
5. Limited 5.1 Non-significant: all
non-significant primary outcomes
5.2 Ambiguous primary outcomes
6. Equal 6.1 Non-significant in superiority
design
6.2 Ambiguous primary outcomes
A study without declared primary outcomes in its full text will be
included in the overstated group.
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Similarly, a ‘limited’ abstract conclusion should corres-
pond to mixed results. An ‘Equal’ abstract conclusion
category must only be populated by non-inferiority trials
showing effectiveness of treatment at least as much as
the control or worse only by a prespeciﬁed amount.
Note that non-inferiority trials are designed and con-
ducted using a speciﬁc methodology under a speciﬁc
design, such as the sample size calculation and equiva-
lence margin prespeciﬁcation. The full-text results
should show that the upper limit of 95% CIs for the dif-
ference between intervention and control lies below that
equivalence margin.12
For a study that does not fall into any of the above pat-




The outcome will be summarised in table 2 as a propor-
tion of the total studies used. Our primary outcome will
be the proportion of overstated abstract conclusions,
that is, the sum of 4.1–6.2.over all studies.
Secondary outcome
We will compare between ‘superior’ and ‘limited’,
namely 4.1 vs 5.1 expressed as a percentage of total
number of studies, respectively. It allows us to predict
that given a type of abstract conclusion, which is more
likely to be overemphasised.
Subgroup analyses
We will investigate the existence of any factors that
potentially inﬂuence these inconsistencies, such as
impact factors (IF) of the journal in which the trials are
published, source(s) of funding and the sample size. For
our purposes, the top 10 impact factor journals as
ranked in Journal Citation Report (2014) in general medi-
cine, psychiatry and psychology will be regarded as high
IF journals.
Amendments
In the case of any amendments added to this protocol,
each amendment will be listed with the date of change
accompanied by a description of the change and the
rationale.
ETHICS AND DISSEMINATION
This trial requires no ethical approval because we use
secondary data from published trial reports. This proto-
col has been registered in the University hospital
Medical Information Network (UMIN) Clinical Trials
Registry. We will publish our ﬁndings in a peer-reviewed
journal and also may present them at conferences.
DISCUSSION
A RCT is methodologically the most robust strategy to
investigate the effectiveness of an intervention and can
be a primary source for reliable evidence; results derived
from RCTs have a strong inﬂuence on clinical judge-
ment. Moreover, proper reporting in the abstract of arti-
cles is crucial to disseminating the results to the public.
However, previous studies have demonstrated that the
outcomes are occasionally positively misrepresented, by
overstating the favourable outcomes and understating
the unfavourable ﬁndings. Our study evaluates overstate-
ments observed in abstracts of published articles in the
ﬁeld of psychiatry. Using a new approach speciﬁcally
designed to minimise the inﬂuence of investigators’ jud-
gements and to maximise the generalisability to the
general setting when articles are read, we aim to evalu-
ate and quantify the magnitude of this problem. Since
this approach is comparable to a systematic review, we
attach the PRISMA-P checklist for reference.13 14
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